Search for: "Harris v. Barnes" Results 101 - 120 of 134
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jul 2018, 3:28 am by Edith Roberts
” For The Washington Post, Robert Barnes and Ann Marimow report that Kavanaugh’s speech “celebrat[ing] his ‘first judicial hero,’ the late Chief Justice William H. [read post]
17 Apr 2008, 11:29 am
Brennan Jr., Thurgood Marshall and Harry A. [read post]
25 Jun 2012, 8:29 am by familoo
Keith Tallon Cook Taylor Caroline Landes   McMillan Williams Helen MacDonald Aitken Associates Martin Wray Aitken Associates Kelly Wild   Aitken Associates Peter Harris Harris Temperley Caron Theobalds Harris Temperley Stewart Hughan Harris Temperley Nina Shaw  Harris Temperley Philip Wilkins  Hudgell & Partners Elizabeth Bendall Sternberg Reed Gordon Reed Sternberg Reed Darren Ward Sternberg Reed Jenny Morrison Morrison… [read post]
15 Jan 2008, 3:06 am
Barnes & Noble Inc et al filed 03/02/07 1:07-cv-01324 Dudkowski v. [read post]
16 Nov 2022, 4:16 am by Emma Snell
Barnes reports for the New York Times. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
12 Jul 2018, 5:06 am by Edith Roberts
” At the Daily Journal (subscription required), David Boyle looks at National Institute of Family and Life Advocates v. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
8 Apr 2014, 4:30 pm by Jeff Foust
Andy Harris (R-MD) asked about contingency plans for the ISS in the event relations worsen. [read post]
6 Jun 2008, 4:23 pm
., asthma, hay fever, eczema); other factors associated with living on a farm such as contact with animals and barns showed a similar effect in these studies. [read post]